Calum D Moulton
Biographic Data
| ID | 8870004 |
|---|---|
| NAME | Calum D Moulton |
| GIVEN NAMES | Calum D |
| FAMILY NAME | Moulton |
| SIGNATURE | MOULTON C D |
| AFFILIATIONS | King's College London |
| ORCID | 0000-0003-0880-4495 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
The Prevalence and Incidence of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Depression and Bipolar Disorder: A Systematic Review and Meta-Analysis
Sitagliptin for Depressive Symptoms in Type 2 Diabetes: A Feasibility Randomized Controlled Trial
OBJECTIVE: We tested the feasibility of using sitagliptin-a dipeptidyl peptidase-IV inhibitor-for depressive symptoms in type 2 diabetes (T2D). METHODS: In a feasibility, double-blind, randomized controlled trial, we recruited people aged 18 to 75 years with T2D (glycated hemoglobin A1c levels ≥53 and ≤86 mmol/mol prescribed oral hypoglycemic therapy) and comorbid depressive symptoms (Patient Health Questionnaire-9 score ≥10) from family practice…
The Association Between Selective Serotonin Reuptake Inhibitors and Glycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
The link between depression and diabetes: The search for shared mechanisms
No prominent works on this page.
The link between depression and diabetes: The search for shared mechanisms
The Association Between Selective Serotonin Reuptake Inhibitors and Glycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Sitagliptin for Depressive Symptoms in Type 2 Diabetes: A Feasibility Randomized Controlled Trial
OBJECTIVE: We tested the feasibility of using sitagliptin-a dipeptidyl peptidase-IV inhibitor-for depressive symptoms in type 2 diabetes (T2D). METHODS: In a feasibility, double-blind, randomized controlled trial, we recruited people aged 18 to 75 years with T2D (glycated hemoglobin A1c levels ≥53 and ≤86 mmol/mol prescribed oral hypoglycemic therapy) and comorbid depressive symptoms (Patient Health Questionnaire-9 score ≥10) from family practice…
The Prevalence and Incidence of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Depression and Bipolar Disorder: A Systematic Review and Meta-Analysis
Diabetes mellitus (2 works) · Endocrinology (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Type 2 diabetes (2 works) · Adverse effect (1 works) · Anxiety (1 works) · Bariatric Surgery and Outcomes (1 works) · Cardiac Health and Mental Health (1 works) · Confidence interval (1 works)